on Defence Therapeutics Inc. (isin : CA24463V1013)
Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto
Defence Therapeutics Inc. announced its participation in the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. The event will be held on June 11, 2024, at the Metro Toronto Convention Centre.
SNMMI is a leading organization promoting the science and practical application of nuclear medicine and molecular imaging. Their annual meeting offers an in-depth view of the latest research in the field, aiming to improve human health. The gathering is recognized as a premier event for networking and professional development in radiotherapy and molecular imaging.
Defence is collaborating with Orano Support SAS to develop AccuTRIC™, a novel Radio-Immuno-Conjugate. This project focuses on utilizing Auger electron emitters to treat hard-to-reach cancers, enhancing the efficacy while minimizing radiotoxicity on healthy tissues.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Defence Therapeutics Inc. news